Human Fibroblast Growth Factor-23 Mutants Suppress Na+-dependent Phosphate Co-transport Activity and 1α,25-Dihydroxyvitamin D3 Production
Top Cited Papers
Open Access
- 1 January 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (4) , 2206-2211
- https://doi.org/10.1074/jbc.m207872200
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Fibroblast Growth Factor (FGF)-23 Inhibits Renal Phosphate Reabsorption by Activation of the Mitogen-activated Protein Kinase PathwayJournal of Biological Chemistry, 2002
- High‐level expression of naked DNA delivered to rat liver via tail vein injectionThe Journal of Gene Medicine, 2002
- Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23Kidney International, 2001
- Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in the Ventrolateral Thalamic Nucleus of the BrainBiochemical and Biophysical Research Communications, 2000
- Continuous Erythropoietin Delivery by Muscle-Targeted Gene Transfer Usingin VivoElectroporationHuman Gene Therapy, 2000
- PHEX gene and hypophosphatemiaKidney International, 2000
- Regulation of Type II Renal Na+-dependent Inorganic Phosphate Transporters by 1,25-Dihydroxyvitamin D3Journal of Biological Chemistry, 1998
- Acute Regulation by Dietary Phosphate of the Sodium-Dependent Phosphate Transporter (NaP1-2) in Rat KidneyThe Journal of Biochemistry, 1997
- Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5Gene, 1989
- Animal Model of Adenine-Induced Chronic Renal Failure in RatsNephron, 1986